Re-inventing tumor targeting
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Latest news
Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas
ESMO Congress 2025
October 17-21, 2025
Berlin, Germany